Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple blood test may predict Post-Surgery confusion in colorectal cancer patients

NCT ID NCT07597330

First seen May 21, 2026 · Last updated Jun 23, 2026 · Updated 7 times

Summary

This study looked at 590 colorectal cancer patients to develop a risk tool that predicts postoperative delirium—a common complication causing confusion and slower recovery. Researchers combined blood test results (including the TyG index) with patient subtypes to create a scoring system. The goal is to help doctors quickly spot high-risk patients and provide targeted care, though this is only a data-collection study and does not test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (MSI-H) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The first hospital of lanzhou university

    Lanzhou, Gansu, 73000, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could give doctors a simple way to identify patients at high risk for confusion after colorectal cancer surgery, allowing for earlier preventive care.

What could go wrong

This is an observational study that only collects data, so it does not test a new treatment. The risk tool may not be accurate enough for routine use and needs further validation.

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.